432 - CCS GUIDELINES RAPID REVIEW SESSION 2

Co-Chair(s)

• 

  David Birnie, MD

  Staff Cardiologist
  University of Ottawa heart institute
  University of Ottawa heart Institute
• JH

  Jonathan Howlett, MD FRCPC FCCS

  Clinical Professor of Medicine
  Foothills Medical Centre
  University of Calgary

Presenter(s)

• 

  David Birnie, MD

  Staff Cardiologist
  University of Ottawa heart institute
  University of Ottawa heart Institute
• 

  Melanie Care, MSc, CCGC (she/her/hers)

  Genetic Counsellor
  Toronto General Hospital/University Health Network
• JH

  Jonathan Howlett, MD FRCPC FCCS

  Clinical Professor of Medicine
  Foothills Medical Centre
  University of Calgary
• 

  Sean Virani, MD MSc MPH (he/him/his)

  President
  Canadian Cardiovascular Society
  St. Paul's Hospital | Providence Health Care

Planning Committee Member(s)

• 

  David Birnie, MD

  Staff Cardiologist
  University of Ottawa heart institute
  University of Ottawa heart Institute
• CG

  Carolyn Gall Casey, BASc

  Director Guidelines and Knowledge Translation
  Canadian Cardiovascular Society
• JH

  Jonathan Howlett, MD FRCPC FCCS

  Clinical Professor of Medicine
  Foothills Medical Centre
  University of Calgary

Presenter(s)

• 

  Jason Andrade, MD (he/him/his)

  Physician
  Canadian Heart Rhythm Society
  Université de Montréal

Workshop Description: CCS Guidelines and Clinical Practice Updates – News from the CPUs, the Guidelines, the Committee and Portfolio

Presentations

• CCS CLINICAL PRACTICE UPDATE ON THE CLINICAL IMPLEMENTATION OF CARDIOGENETIC TESTING - Melanie Care
  
• CCS/CHFS 2025 GUIDELINE UPDATE FOR PHARMACOLOGIC MANAGEMENT OF HEART FAILURE WITH NON-REDUCED EJECTION FRACTION (LV EJECTION FRACTION > 40%) - Sean Virani
  
• CCS/CHRS GUIDELINE FOR THE MANAGEMENT OF CARDIAC IMPLANTABLE ELECTRONIC DEVICES -
  
• Live Q&A - Evaluate the second session, answer questions for strategic planning
  
• Closing Remarks - Jonathan Howlett
  
• Looking forward: CCS Guidelines Program - David Birnie

  Learning Objectives:

  At the end of this session participants will be able to:

  • list the top key messages and recommendations from the latest Guidelines and CPUs;
  • apply Guideline recommendations and CPU guidance in practice, individualizing for unique patient needs; and
  • understand changes and updates in CCS’s Guidelines portfolio.